Research Advances in Hypoglycemic Activity of Lactic Acid Bacteria

doi:A

Abstract

Abstract: Hypoglycemic activities of many kinds of lactic acid bacteria have been proved．The article summarized current clinical applications and the research progress on hypoglycemic activity of lactic acid bacteria, and their hypoglycemic mechanism and bioactive compounds were analyzed. The safety and the future direction of research in this field were also discussed. The results of this study provided reference for exploiting new hypoglycemic drug from lactic acid bacteria for the treatment of diabetes.

Key words: lactic acid bacteria, diabetes mellitus, hypoglycemic activity, mechanism

CLC Number:

R284.2

FAN Wen-ya, WU Zheng-jun, GUO Ben-heng. Research Advances in Hypoglycemic Activity of Lactic Acid Bacteria[J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2012, 23(09): 1323-.

References

1 Guo BH(郭本恒).Probiotics.Beijing:Chemical Industry Press,2004:61-62.
2 Yun SI,et al.Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes.Appl Microbiol,2009,107:1681-1686.
3 Yadav H,et al.Effect of probiotic dahi containing lactococcus lactis on the progression of diabetes induced by a high fructose diet in rats.Biosci Biotechnol Biochem,2006,70:1255-1258.
4 Watts T,et al.Role of the intestinal tight junetion modulator zonulin in the Pathogenesis of type1diabetes in BB diabetic-prone rats.Proc Natl Acad Sci USA,2005,102:2916-2921.
5 Dumas ME.Metabolic profiling reveals a contribution of gut mierobiota to fatty liver phenotype in insulin-resistant mice.Proc Natl Acad Sci USA,2006,103:12511-12516.
6 Neal MD,et al.Enteroeyte TLR4 mediates phagocytosis and translocation of baeteria across the intestinal barrier.J Immunol,2006,176:3070-3079.
7 Bie MJ(别明江),LIU X(刘祥).Study on the relationship between the blood sugar levels and microflora in diabetic mouse model.Mod Prev Med(现代预防医学),2005,32:1441-1443.
8 Ewaschuk JB,et al.Surface expression of Toll-like receptor 9 is up regulated on intestinal epithelial cells in response to pathogenic bacterial DNA.Infect Immun,2007,75:2572-2579.
9 Van GA,et al.Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii,LA1) on early endoscopic recurrence of Crohn′s disease after ileo-caecal resection.Inflamm Bowel Dis,2007,13:135-142.
10 Michail S,Abernathy F.Lactobacillus plantarum inhibits the intestinal epithelial migration of neutrophils induced by enteropathogenic Escherichia coli.J Pediatr Gastroenterol Nutr,2003,36:385-391.
11 Huang H(黄回),Han CM(韩春茂).Effects of Lactobacillus ecological immune nutrition in maintaining bowel mucosa barrier.Chin J Burns(中华烧伤杂志),2005,21:155-157.
12 Calcinaro F.Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse.Diabetologia,2005,48:1565-75.
13 Matsuzaki T.Antidiabetic effects of an oral administration of Lactobacillus casei in a non –insulin-dependent diabetes mellitus(NIDDM)model using KK-AY mice.Endocr J,1997,44:357-65.
14 Gronlund MM,et al.Importance of interstin colonization in the maturation of humoral immunity in early infaney:prospective follow-up study of healthy infants aged 0-6 months.Arch Dis Child,2000,83:186-192.
15 Freitas M,et al.Host-pathogens crosstalk Indigenous bacteria and probiotics also play the game.Biol Cell,2003,95:503-506.
16 Galdeano C M,et al.Proposed model:mechanisms of immunomodulation induced by probiotic bacteria.Clin Vaccine Immunol,2007,14:485-492.
17 Cross ML.Microbes versusm icrobes immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens.FEMS Immunol Med Microbiol,2002,34:245-248.
18 Feinstein R,et al.Tumor necrosis factor-a suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.J Biol Chem,1993,268:26055 -26058.
19 Mandrup PT,et al.Cytokines and free radicals as effector molecules in the destruction of pancreatic D-cells.Curr Top Microbiol Immunol,1990,164:169-193.
20 Hotamisligil GS,et al.Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes.Central role of tumor necrosis factor-a.J Clin Invest,1994:1543 -1549.
21 Del RA,Besedovsky H.Antidiabetic effects of interleukin 1.Pro Natl Acad Sci,1989:5943-5949.
22 Maritim AC,et al.Diabetes,oxidative stress and antioxidant:a review.J Biochem Mol Toxical,2003,17:24-38.
23 Fang M(方明),et al.The control of Ⅱdiabetes blood and correlation analysis of oxidative stress,NO,CRP.Zheiiang J Integr Tradit Chin West Med(浙江中西医结合杂志),2008,18:87-88.
24 Li XL(李晓林),et al.The content changes of SOD and MDAin important organic tissues of adult diabetic rat.Chin J Gerontol (中国老年学杂志),2005,25:412-413.
25 Lapidot T,et al.Antioxidant and prooxidant effects of phenolics on pancreatic β-cells in vitro.J Agric Food Chem,2002,50:7220-7225.
26 26.Evans JL,et al.Are oxidative stress-activated signaling pathway smediators of insulin resistanceand beta-celldysfunction? Diabetes,2003,52(1):1-8.
27 Maritim AC,et al.Diabetes Oxidative stress and anfiofidants:A review.J Biochem Mol Toxicol,2003,17:24-37.
28 Jeongmn L,et al.Resistance of Lactobacillus casei KCTC 3260 to reactive oxygen species (ROS):role for a metal ion chelating effect.J Food Sci,2005,70:388-391.
29 Meng HBLG(孟和毕力格),et al.Antioxidative effect of Lactobacillus MG2-1 in Koumiss.Chin Dairy Ind(中国乳品工业),2005,33:24-29.
30 Yadav H,et al.Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats.Nutr,2007,23:62-68.
31 Willcox J K,et al.Antioxidants and prevention of chronic disease.Crit Rev Food Sci Nutr,2004,44:275-295.
32 Li GW(李光伟),Ning G(宁光).Zhou ZG(周智广).Primary intensive insulin therapy improves islet β-cell function in type 2 diabetes A dream or reality?Chin J Endocr Metab(中华内分泌代谢杂志),2006,22:309-312
33 Matsuzaki T,et al.Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice.APMIS,1997,105:637-642.
34 Tabuchi M.Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats.Biosci Biotechnol Biochem,2003,67:1421-1424.
35 Anne.S A,et al.Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects..Br J Nutr,2010,1-8.
36 Kong LF(孔令芳),et al.Influence of chromium trichloride on erythrocytic insulin receptor of patients with type 2 diabetes mellitus.Chin J Mod Med (中国现代医学杂志),2005,15:3089-3092.
37 Hiroaki M,et al.Effect of an exopolysaccharide(kefiran) form lactobacillus kefiranofaciens on blood glucose in KKAy mice and constipation in SD rats induced by a low-fiber diet.Biosci Microfl,2004,23:149-153.
38 Toshihiko Y,et al.Effects of the probiotic strain Lactobacillus johnsonii strain La1 on autonomic nerves and blood glucose in rats.Life Sci,2006,79:1963-1967.
39 Xu LL(徐灵龙),et al.Research on the inhibitory effect of Lactobacillus against Escherichia coli.J Chin Electr Microsc Soc(电子显微学报),2005,24:17.
40 Levettan C.Oral antidiabetic agents in type 2 diabetes.Curr Med Res Opin,2007,23:945 -952.
41 Chen SW(陈思维),et al.Expression of human insulin in lactic acid bacteria and its oral administration in non-obese diabetic mice.Acta Microbiol Sin(微生物学报),2007,47:987-991.
42 Zein EF,et al.Lactobacillus rhamnosus septicemia in a diabetic patient associated with probiotic use:a case report.Ann Biol Clin (Paris),2008,66:195-198.

[1]	WANG Ning, GE Jin. Mechanism of Xiaoyao Wan in the treatment of liver cirrhosis based on network pharmacology analysis and in vitro experiments [J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2024, 36(增刊1): 121-132.
[2]	FENG Chao-ying, GAO Lu, SUN Mei-hao, GONG Ju-fang, PU Shou-cheng. Mechanism of Huangqi Gegen decoction on COVID-19 and diabetes mellitus based on enzymology,network pharmacology and molecular simulation [J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2024, 36(增刊1): 133-146.
[3]	ZHU Zi-mo, CUI Bai-mei, NIE Fa-long, XIAO Chun, LI Xiu-fang. Arctigenin alleviates acute lung injury by inhibiting the inflammation reaction and repairing the nasal epithelial barrier [J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2024, 36(8): 1298-1306.
[4]	LI Ru, CHEN Xue-lin, WANG Han-lei, ZHANG Zhen-nan, ZHAO Xia, ZHANG Ku, ZHANG Yu-mei. Chemical constituents from roots of Adina rubella and their α-glucosidase inhibitory activity [J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2024, 36(8): 1307-1319.
[5]	SUN Yue, BAO Xu-hong, LIU Wen-wei, ZHANG Guo-xia. Research progress on the pharmacological action and mechanism of echinacoside [J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2024, 36(8): 1445-1455.
[6]	ZHANG Ya-lun, ZHU Yan-jie, DAI Xiang-yang, WANG Xiao-lan, HAO Zhi-you, SUN Yan-jun, FENG Wei-sheng, CHEN Hui. Chemical constituents from the leaves of Cinnamomum cassia [J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2024, 36(7): 1142-1148.
[7]	HUANG Li-rong, YU Jia, LI Jiao, CHENG Sha, LUO Heng. Anti-prostate cancer activity and mechanism of different solvent extracts of Anemones Rivularis Radix based on network pharmacology and experimental validation [J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2024, 36(7): 1231-1241.
[8]	LU Guo-di, HOU Jia, QIANG Zheng-ze, YANG Fu-de. Application of omics technologies in the quality evaluation and pharmacological mechanism study of Astragali Radix [J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2024, 36(7): 1257-1265.
[9]	SONG Yu, JI Li-lian, LIU Yan-li, WANG Tao-yun. Research progress on chemical constituents and pharmacological activities of Ilex cornuta [J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2024, 36(6): 1082-1099.
[10]	ZHU Jia-na, TIAN Hong-qiao, LIU Meng-long, DING Hai-yan . Molecular mechanism of Cladonia stellaris against MRSA based on metabolomics and molecular docking [J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2024, 36(10): 1732-1741.
[11]	QIU Wei-chen, YUN Yi-xuan, JIANG Xiao-gang. Research progress on pharmacological effects of trehalose [J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2024, 36(10): 1813-1819.
[12]	WU Nan-nan, SUN Jin-yue, HE Cong-fen. Anti-inflammatory active ingredients and mechanism of oil peony based on network pharmacology [J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2023, 35(增刊2): 104-115.
[13]	CHEN Xiang-lin, PENG Zhao-xuan, ZHANG Yu-rong, PENG Yi-chen, WANG Jing. Intervention mechanism of Heshu Xiaoji pills on liver cancer based on network pharmacology and molecular docking [J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2023, 35(增刊2): 116-124.
[14]	SUN Juan, CHEN Jie-wen, ZHANG Hai-feng, LIU Xi-peng. The interaction between vitamin D and chronic kidney disease based on network pharmacology [J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2023, 35(增刊2): 136-138.
[15]	ZHAO Quan, DAI Guo-liang, XU Mei-juan, OUYANG Bing-chen, JIANG Ting, YAN Xiao-jing, ZHANG Wei-dong. Investigation on the pharmacodynamic material basis and mechanism of Simotang oral liquid against depression based on HPLC-Q-TOF-MS/MS and network pharmacology [J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2023, 35(增刊1): 144-152.